BrainCheck Achieves HITRUST i1 Certification, Demonstrating Commitment to Cybersecurity and Information Protection

Audio By Carbonatix

AUSTIN, Texas--(BUSINESS WIRE)--Jan 21, 2026--

BrainCheck, the leading FDA Class II digital cognitive assessment and care platform, today announced that its BrainCheck Platform, hosted on Amazon Web Services (AWS), has earned HITRUST CSF Certified status for cybersecurity and information protection.

The HITRUST Certification demonstrates that the BrainCheck Platform has met requirements defined by leading cybersecurity and regulatory frameworks, confirming that strong controls are in place to protect sensitive data and manage risk effectively.

Built on the HITRUST Assurance Program, this achievement reflects independent third-party testing, centralized quality assurance, and certification backed by HITRUST’s Cyber Threat-Adaptive engine. These elements ensure continuous alignment with the latest threat intelligence and evolving standards across NIST, ISO, and OWASP.

“As cybersecurity expectations rise, our stakeholders expect credible, validated assurance,” said Bassel Samman, CTO at BrainCheck. “Achieving HITRUST Certification reinforces our ongoing commitment to protecting data, managing risk, and maintaining the trust of those we serve.”

“Earning HITRUST Certification demonstrates BrainCheck’s commitment to managing information risk and protecting sensitive data through a rigorous, proven assurance process,” said Gregory Webb, CEO of HITRUST. “This achievement reflects the organization’s proactive approach to cybersecurity and trust.”

To learn more, visit www.braincheck.com.

About BrainCheck

BrainCheck is an FDA Class II–cleared digital platform for cognitive assessment and care, used by over 500 healthcare organizations nationwide, including Bon Secours, UPMC, and Springfield Clinic. Clinicians use BrainCheck’s validated screeners and care planning tools to create tailored protocols, completing more than 400,000 cognitive assessments to date. BrainCheck is not intended for use as a stand-alone diagnostic tool.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260121749604/en/

CONTACT: BrainCheck Media Contact

Kate Smith

Senior Marketing Specialist

BrainCheck Inc

[email protected]

KEYWORD: TEXAS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: MENTAL HEALTH SECURITY MEDICAL DEVICES HEALTH TECHNOLOGY HEALTH TECHNOLOGY

SOURCE: BrainCheck

Copyright Business Wire 2026.

PUB: 01/21/2026 09:00 AM/DISC: 01/21/2026 09:04 AM

http://www.businesswire.com/news/home/20260121749604/en